An interdisciplinary team of international experts selected during the crowdsourcing competition jointly organised by Boehringer Ingelheim and BioMed X will focus on developing a highly integrated brain microcircuit model which includes authentic neuronal and non-neuronal cells and supports functional readouts with sufficient robustness and throughput for drug discovery in psychiatric diseases. The team will be established in the BioMed X Innovation Center in Heidelberg, Germany. The research will be sponsored by Boehringer Ingelheim for two years, with the option to extend the funding period up to a total of four years.